None listed
Conditions
Interventions
None listed
Sponsors
Shikha Dixit
Eligibility
Inclusion criteria
Inclusion criteria: Survey will be carried out in individuals above 2 years of age (no upper limit on age) and all individuals currently residing and likely to stay till the end of study (1 year) in the study area will be considered eligible for inclusion.
Exclusion criteria
Exclusion criteria: Individuals who are unlikely to stay in the study area for the next 1 year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary objectives I. Estimate the sero-prevalence of SARS-CoV-2 infection in the general population II. Estimate the 4 monthly incidence of SARS-CoV-2 infection based on serial sero-surveys III. Estimate cumulative sero-conversion of SARS-CoV-2 infection over one year period IV. Estimate the sero-prevalence and annual sero conversion of Dengue and Chikungunya in a sub sample of the studyTimepoint: Sero-prevalence of COVID will be assessed at baseline, 4 months, 8 months and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objectives I. Monitor the trend of SARS-CoV-2 transmission in the general population II. Determine the prevalence and incidence of SARS CoV2 sero-positivity among the members of the households with at least one seropositive individual (clustering of infection at household level) Determine the risk factors for SARS-CoV-2 infection III. Determine the duration of persistence of antibodies in individuals tested positive for SARS-CoV-2 infection Timepoint: Trend of infection and duration of persistence of antibodies will be monitored by the serial sero-surveys at 0,4,8 and 12 months. Incidence of symptomatic infections will be assessed via fortnightly phone calls. | — |
Countries
India
Contacts
Public ContactDivya Nair
The INCLEN Trust International
Outcome results
None listed